Related Experiment Video
Updated: Mar 19, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Obstructive Hypertrophic Cardiomyopathy With Degenerative Mitral Regurgitation: A New Treatment Strategy Using
Yu Wang1, Xiangjuan Liu1, Lianyue Ma1
1State Key Laboratory for Innovation and Transformation of Luobing Theory, Jinan, China; Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province, Jinan, China; Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.
Background:
Transcatheter edge-to-edge mitral valve repair (M-TEER) has been demonstrated as an effective therapeutic option for patients with obstructive hypertrophic cardiomyopathy (oHCM) and concomitant degenerative mitral regurgitation. Mavacamten is a mechanism-based therapy for oHCM that can improve hemodynamics. However, clinical evidence on the concomitant use of mavacamten and M-TEER remains limited, and related case reports are scarce.
Case Summary:
We present the case of a 79-year-old woman with symptomatic severe oHCM complicated by mitral valve prolapse, aortic stenosis, and secondary tricuspid regurgitation. Under the combined strategy of mavacamten and M-TEER, the patient experienced significant improvements in both symptoms and hemodynamics.
Discussion:
In oHCM, identifying the underlying mechanism of mitral regurgitation is crucial for therapeutic decision-making. Direct M-TEER in the setting of severe left ventricular outflow tract obstruction may carry specific risks and uncertainties. A stepwise strategy using mavacamten followed by M-TEER may reduce procedural risk while achieving more stable clinical and hemodynamic improvement.
Take-Home Message:
For oHCM patients with concomitant degenerative mitral regurgitation, the combined treatment of mavacamten and M-TEER represents a potential therapeutic option with complementary mechanisms.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation IV: Nursing Management

